The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product

Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · see citing works

Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53

Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562 · see citing works

T antigen is bound to a host protein in SY40-transformed cells

Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,443 · see citing works

Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas

Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,067 · see citing works

The p53 proto-oncogene can act as a suppressor of transformation

Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987 · see citing works

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814 · see citing works

Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53

Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742 · see citing works

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483 · see citing works

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459 · see citing works

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403 · see citing works

The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes

Münger, K., Phelps, W. C., Bubb, V. J., Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,335 · see citing works

Allelotype of Colorectal Carcinomas

Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., & White, R. L. (1989) · Science · doi:10.1126/science.2565047 · Cited by 1,302 · see citing works

Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

Münger, K., Werness, B. A., Dyson, N. J., Phelps, W. C., Harlow, E. E., & Howley, P. M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08594.x · Cited by 1,204 · see citing works

p53: A Frequent Target for Genetic Abnormalities in Lung Cancer

Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M. L., Pass, H. I., Gazdar, A. F., & Minna, J. D. (1989) · Science · doi:10.1126/science.2554494 · Cited by 1,196 · see citing works

Activating Mutations for Transformation by p53 Produce a Gene Product That Forms an hsc70-p53 Complex with an Altered Half-Life

Finlay, C. A., Hinds, P. W., Tan, T., Eliyahu, D., Oren, M., & Levine, A. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.531 · Cited by 1,144 · see citing works

HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

Hawley‐Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., & Schiller, J. T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08570.x · Cited by 914 · see citing works

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

Sarnow, P., Ho, Y.-S., Williams, J., & Levine, A. J. (1982) · Cell · doi:10.1016/0092-8674(82)90356-7 · Cited by 836 · see citing works

Presence of a Potent Transcription Activating Sequence in the p53 Protein

Fields, S., & Jang, S. K. (1990) · Science · doi:10.1126/science.2144363 · Cited by 790 · see citing works

Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation

Parada, L. F., Land, H., Weinberg, R. A., Wolf, D., & Rotter, V. (1984) · Nature · doi:10.1038/312649a0 · Cited by 731 · see citing works

Cellular targets for transformation by the adenovirus E1A proteins

Whyte, P., Williamson, N. M., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90984-7 · Cited by 729 · see citing works

Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

Eliyahu, D., Raz, A., Gruß, P., Givol, D., & Oren, M. (1984) · Nature · doi:10.1038/312646a0 · Cited by 706 · see citing works

Wild-type p53 can inhibit oncogene-mediated focus formation.

Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., & Oren, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8763 · Cited by 681 · see citing works

Heterogeneity of the human papillomavirus group

de Villiers, E. M. (1989) · Journal of Virology · doi:10.1128/jvi.63.11.4898-4903.1989 · Cited by 668 · see citing works

Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein.

Smotkin, D., & Wettstein, F. O. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4680 · Cited by 661 · see citing works

The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A

Phelps, W. C., Yee, C., Münger, K., & Howley, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90570-3 · Cited by 641 · see citing works

Transcriptional Activation by Wild-Type but Not Transforming Mutants of the p53 Anti-Oncogene

Raycroft, L., Wu, H., & Lozano, G. (1990) · Science · doi:10.1126/science.2144364 · Cited by 620 · see citing works

Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

Yee, C., Krishnan-Hewlett, I., Baker, C. C., et al. (1985) · PubMed · Cited by 607 · see citing works

Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation

Hinds, P. W., Finlay, C. A., & Levine, A. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.739-746.1989 · Cited by 595 · see citing works

Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

Jenkins, J. R., Rudge, K., & Currie, G. A. (1984) · Nature · doi:10.1038/312651a0 · Cited by 538 · see citing works

Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.

Oren, M., Maltzman, W., & Levine, A. J. (1981) · Molecular and Cellular Biology · doi:10.1128/mcb.1.2.101 · Cited by 489 · see citing works

The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates.

Haas, A. L., & Bright, P. M. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38895-6 · Cited by 382 · see citing works

Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus

Mowat, M. R. A., Cheng, A., Kimura, N., Bernstein, A., & Benchimol, S. (1985) · Nature · doi:10.1038/314633a0 · Cited by 320 · see citing works

Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53.

Reich, N. C., Oren, M., & Levine, A. J. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.12.2143 · Cited by 310 · see citing works

Comparison of the in vitro transforming activities of human papillomavirus types.

Storey, A., Pim, D. C., Murray, A., Osborn, K., Banks, L., & Crawford, L. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03013.x · Cited by 301 · see citing works

The Role of Papillomaviruses in Human Anogenital Cancer

Hausen, H. Z., & Schneider, A. (1987) · Springer eBooks · doi:10.1007/978-1-4757-0584-3_9 · Cited by 272 · see citing works

Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene

Wolf, D., Harris, N., & Rotter, V. (1984) · Cell · doi:10.1016/0092-8674(84)90532-4 · Cited by 245 · see citing works

Meth A fibrosarcoma cells express two transforming mutant p53 species.

Eliyahu, D., Goldfinger, N., Pinhasi-Kimhi, O., Shaulsky, G., Skurnik, Y. D., Arai, N., Rotter, V., & Oren, M. (1988) · PubMed · Cited by 233 · see citing works

An N-Terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110 and a second cellular protein, p120

Ewen, M. E., Ludlow, J. W., Marsilio, E., DeCaprio, J. A., Millikan, R. C., Cheng, S. H., Paucha, E., & Livingston, D. M. (1989) · Cell · doi:10.1016/0092-8674(89)90840-4 · Cited by 228 · see citing works

Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

Zakut, R., Bienz-Tadmor, B., Givol, D., & Oren, M. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03768.x · Cited by 218 · see citing works

Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7

Watanabe, S., Kanda, T., & Yoshiike, K. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.965-969.1989 · Cited by 174 · see citing works

Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells

Bedell, M. A., Jones, K. H., Grossman, S. R., et al. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1247-1255.1989 · Cited by 169 · see citing works

Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.

Rovinski, B., & Benchimol, S. (1988) · PubMed · Cited by 156 · see citing works

Cis-trans recognition and subunit-specific degradation of short-lived proteins

Johnson, E. S., Gonda, D. K., & Varshavsky, A. (1990) · Nature · doi:10.1038/346287a0 · Cited by 152 · see citing works

Analysis of human p53 proteins and mRNA levels in normal and transformed cells

Matlashewski, G., Banks, L., Pim, D., & Crawford, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09449.x · Cited by 137 · see citing works

The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene.

Kh, V., Doniger, J., DiPaolo, J. A., et al. (1988) · PubMed · Cited by 129 · see citing works

How are substrates recognized by the ubiquitin-mediated proteolytic system

Ciechanover, A. J., & Schwartz, A. L. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90180-1 · Cited by 127 · see citing works

Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A, and myc oncoproteins

Figge, J. J., Webster, T. A., Smith, T. F., & Paucha, E. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1814-1818.1988 · Cited by 117 · see citing works

Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter

Kanda, T., Watanabe, S., & Yoshiike, K. (1988) · Virology · doi:10.1016/0042-6822(88)90694-0 · Cited by 112 · see citing works

Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18

Gius, D. R., Grossman, S. R., Bedell, M. A., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.3.665-672.1988 · Cited by 93 · see citing works

Wild type human p53 is antiproliferative in SV40-transformed hamster cells.

Mercer, W. E., Amin, M., Sauvé, G. J., Appella, E., Sj, U., & Romano, J. (1990) · PubMed · Cited by 91 · see citing works

Identification of a transforming gene of human papillomavirus type 16

Tanaka, A., Noda, T., Yajima, H., et al. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1465-1469.1989 · Cited by 71 · see citing works

Transforming collaborations between ras and nuclear oncogenes.

He, R. (1990) · PubMed · Cited by 70 · see citing works

Transformation of rat 3Y1 cells by human papillomavirus type‐18 DNA

Watanabe, S., & Yoshiike, K. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410622 · Cited by 55 · see citing works

Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein.

Lamberti, C., Morrissey, L. C., Grossman, S. R., et al. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08317.x · Cited by 52 · see citing works

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · see citing works

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · see citing works

Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations

Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · see citing works

The first 30 years of p53: growing ever more complex.

Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967 · see citing works

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626 · see citing works

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells

Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206 · see citing works

ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1

Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091 · see citing works

p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2

Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086 · see citing works

Targeting p53 pathways: mechanisms, structures, and advances in therapy

Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016 · see citing works

The MDM2 gene amplification database

Momand, J. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.15.3453 · Cited by 982 · see citing works

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α

Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967 · see citing works

Gain of function mutations in p53

Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894 · see citing works

A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879 · see citing works

The N-end rule: functions, mysteries, uses

Varshavsky, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12142 · Cited by 859 · see citing works

MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells

Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705 · see citing works

MDMX: a novel p53‐binding protein with some functional properties of MDM2.

Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · see citing works

Wild-type p53 activates transcription in vitro

Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579 · see citing works

p300/MDM2 complexes participate in MDM2-mediated p53 degradation

Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z.-X., Kumar, S., Howley, P. M., & Livingston, D. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80140-9 · Cited by 414 · see citing works

The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.

Finlay, C. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.301 · Cited by 311 · see citing works

Regulation of the Human hsp70 Promoter by p53

Agoff, S. N., Hou, J., Linzer, D. I., & Wu, B. (1993) · Science · doi:10.1126/science.8418500 · Cited by 292 · see citing works

Interaction of Papillomavirus E6 Oncoproteins with a Putative Calcium-Binding Protein

Chen, J. J., Reid, C. E., Band, V., & Androphy, E. J. (1995) · Science · doi:10.1126/science.7624774 · Cited by 275 · see citing works

Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1

Hara, E., Tsurui, H., Shinozaki, A., Nakada, S., & Oda, K. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91403-y · Cited by 260 · see citing works

DNA Damage Signaling and p53-dependent Senescence after Prolonged β-Interferon Stimulation

Moiseeva, O., Mallette, F. A., Mukhopadhyay, U. K., Moores, A., & Ferbeyre, G. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-09-0858 · Cited by 252 · see citing works

The proteasome in brain aging

Keller, J. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(01)00006-x · Cited by 247 · see citing works

Mdm2 binds p73α without targeting degradation

Bálint, E., Bates, S., & Vousden, K. H. (1999) · Oncogene · doi:10.1038/sj.onc.1202781 · Cited by 212 · see citing works

Cancer cell signaling pathways targeted by spice-derived nutraceuticals

Sung, B., Prasad, S., Yadav, V. R., & Aggarwal, B. B. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.630551 · Cited by 204 · see citing works

Chasing molecular glue degraders: screening approaches

Domostegui, A., Nieto-Barrado, L., Perez-Lopez, C., & Mayor-Ruiz, C. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00197g · Cited by 200 · see citing works

Structural and Functional Analysis of E6 Oncoprotein: Insights in the Molecular Pathways of Human Papillomavirus-Mediated Pathogenesis

Nominé, Y., Masson, M., Charbonnier, S., Zanier, K., Ristriani, T., Deryckère, F., Sibler, A.-P., Desplancq, D., Atkinson, R. A., Weiss, E., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.024 · Cited by 177 · see citing works

The many faces of p53: something for everyone

Levine, A. J. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz026 · Cited by 163 · see citing works

Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock

Munro, J., Barr, N. I., Ireland, H., Morrison, V., & Parkinson, E. K. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.017 · Cited by 141 · see citing works

Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling

Brimer, N., Lyons, C., Wallberg, A. E., & Vande Pol, S. B. (2012) · Oncogene · doi:10.1038/onc.2011.589 · Cited by 133 · see citing works

Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3

LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122 · see citing works

Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter

Shivakumar, C. V., Brown, D. R., Deb, S., & Deb, S. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6785 · Cited by 120 · see citing works

P53 and The Immune Response: 40 Years of Exploration—A Plan for the Future

Levine, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020541 · Cited by 97 · see citing works

c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination

Vogt Sionov, R., Coen, S., Goldberg, Z., Berger, M., Bercovich, B., Ben-Neriah, Y., Ciechanover, A., & Haupt, Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5869-5878.2001 · Cited by 94 · see citing works

Replicative senescence revisited.

Marcotte, R., & Wang, E. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.b257 · Cited by 86 · see citing works

Targeting Therapies for the p53 Protein in Cancer Treatments

Levine, A. J. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055455 · Cited by 84 · see citing works

The G2 DNA Damage Checkpoint Delays Expression of Genes Encoding Mitotic Regulators

Crawford, D. F., & Piwnica-Worms, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103414200 · Cited by 79 · see citing works

Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway

Bang, S., Kaur, S., & Kurokawa, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010261 · Cited by 69 · see citing works

The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase

Sanduja, S., Kaza, V., & Dixon, D. A. (2009) · Aging · doi:10.18632/aging.100086 · Cited by 65 · see citing works

Enzyme-substrate relationships in the ubiquitin system: approaches for identifying substrates of ubiquitin ligases

O’Connor, H. F., & Huibregtse, J. M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2529-6 · Cited by 42 · see citing works

The struggle of a good friend getting old: cellular senescence in viral responses and therapy

Kohli, J., Veenstra, I., & Demaria, M. (2021) · The EMBO Reports · doi:10.15252/embr.202052243 · Cited by 52 · see citing works

Anti‐leukaemic effects induced by APR‐246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute myeloid leukaemia cells

Ali, D., Mohammad, D. K., Mujahed, H., Jonson‐Videsäter, K., Nore, B., Paul, C., & Lehmann, S. (2016) · British Journal of Haematology · doi:10.1111/bjh.14036 · Cited by 49 · see citing works

Viral hijacking of host caspases: an emerging category of pathogen–host interactions

Connolly, P. F., & Fearnhead, H. O. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.59 · Cited by 44 · see citing works

Insights into regulators of p53 acetylation

Nagasaka, M., Miyajima, C., Aoki, H., Aoyama, M., Morishita, D., Inoue, Y., & Hayashi, H. (2022) · Cells · doi:10.3390/cells11233825 · Cited by 45 · see citing works

Small-molecule correctors and stabilizers to target p53

Fallatah, M. M. J., Law, F. V., Chow, W. A., & Kaiser, P. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.02.007 · Cited by 44 · see citing works

Human papillomavirus 16-specific T-cell responses and spontaneous regression of anal high-grade squamous intraepithelial lesions.

Tong, W. W. Y., Shepherd, K., Garland, S., Meagher, A., Templeton, D. J., Fairley, C. K., Jin, F., Poynten, I. M., Zaunders, J., Hillman, R. J., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu461 · Cited by 36 · see citing works

p53 is dispensable for UV-induced cell cycle arrest at late G1 in mammalian cells

Al-Mohanna, M. A., Al-Khodairy, F. M., Krezolek, Z., Bertilsson, P.-A., Al-Houssein, K. A., & Aboussekhra, A. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.573 · Cited by 30 · see citing works

Human papilloma virus, papanicolaou smears, and the college female

Moscicki, A.-B. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2004.10.005 · Cited by 24 · see citing works

Interleukin-1α associates with the tumor suppressor p53 following DNA damage

Novak, J., Zamostna, B., Vopalensky, V., Buryskova, M., Burysek, L., Doleckova, D., & Pospisek, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-63779-x · Cited by 3 · see citing works

Oncogenes and tumor suppressor genes.

Weinberg, R. A. (1988) · PubMed

THE SIGNIFICANCE OF TUMOR SUPRESSOR GENES INACTIVATION IN CARCINOGENESIS OF MULTIPLE PRIMARY NEOPLASM

Ju, J. (2000) · Chinese Journal of Bases and Clincs In General Surgery

[Tumor suppressor gene: implication in the clinical medicine].

Takai, S., Tanaka, N., Shin, E., et al. (1990) · PubMed · Cited by 1 · see citing works

Tumor Suppressor Genes: The Puzzle and the Promise

Sager, R. (1989) · Science · doi:10.1126/science.2574499 · Cited by 477 · see citing works

Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color doppler ultrasound, immunohistochemistry, and microvessel density

Emoto, M., Iwasaki, H., Mimura, K., Kawarabayashi, T., & Kikuchi, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970901)80:5 · Cited by 77 · see citing works